Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic Review

(2014) Guillaume Ploussard et al.   EUROPEAN UROLOGY

Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

(2014) Raymond H. Mak et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial

(2013) Timur Mitin et al.   LANCET ONCOLOGY

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical Cystectomy and Bladder Preservation for Muscle-Invasive Urothelial Carcinoma of the Bladder

(2012) Georgios Gakis et al.   EUROPEAN UROLOGY

Results of the SPARE Feasibility Study – Selective Bladder Preservation Against Radical Excision in Muscle Invasive T2/T3 Transitional Cell Carcinoma of the Bladder (CRUK/07/011)

(2012) R. Huddart et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

(2012) Nicholas D. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

(2011) Jason A. Efstathiou et al.   EUROPEAN UROLOGY

Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

(2011) Ananya Choudhury et al.   JOURNAL OF CLINICAL ONCOLOGY

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

(2011)   JOURNAL OF CLINICAL ONCOLOGY

Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011)

(2011) Sangeetha Paramasivan et al.   Trials

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

(2010) A. Choudhury et al.   CANCER RESEARCH

Robotic-Assisted Laparoscopic Intracorporeal Urinary Diversion

(2010) Raj S. Pruthi et al.   EUROPEAN UROLOGY

Radiotherapy With Concurrent Carbogen and Nicotinamide in Bladder Carcinoma

(2010) Peter J. Hoskin et al.   JOURNAL OF CLINICAL ONCOLOGY

Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06

(2009) Jason A. Efstathiou et al.   JOURNAL OF CLINICAL ONCOLOGY

A Sequential Treatment Approach to Myoinvasive Urothelial Cancer: A Phase II Southwest Oncology Group Trial (S0219)

(2009) Ralph W. deVere White et al.   JOURNAL OF UROLOGY